How much has Vivace Therapeutics raised?
$105.0Macross 4 recorded rounds · Jan 2015 – Feb 2025
Most recently, Vivace Therapeutics raised $35.0M in its Later Stage VC (Series D) (Feb 2025).
Free account
More of Vivace Therapeutics with a free account
- ·The complete investor list: 11 names
- ·Watch Vivace Therapeutics: the Monday email on marks, rounds and moves
Vivace Therapeutics round by round
4 roundsFeb 2025Later Stage VC (Series D)$35.0M▮
+ 1 more investors · free account
6 investors participated
6 investors participated
3 investors participated
How much has Vivace Therapeutics raised?
Vivace Therapeutics has raised $105 million across 4 recorded rounds since 2015. The largest was an $8 million early-stage round in May 2017; the most recent was a $35 million Series D in Feb 2025.
Vivace Therapeutics has filed 5 Form Ds with the SEC since 2015, most recently in Mar 2025 ($17.5 million sold to 5 investors).
Vivace Therapeutics investors
11 investors are on record for Vivace Therapeutics, including Sequoia Capital, Hongshan Capital Group, RA Capital Management and Canaan Partners. The Series D in Feb 2025 drew 2 investors.
For fundraisers
Raising for a company like Vivace Therapeutics?
11 investors have backed Vivace Therapeutics — start your target list with the firms already writing checks in drug discovery.
Frequently asked about Vivace Therapeutics
- How much has Vivace Therapeutics raised?
- Vivace Therapeutics has raised $105.0M in total across 4 recorded funding rounds.
- When was Vivace Therapeutics's last funding round?
- Vivace Therapeutics's most recent recorded round was Later Stage VC (Series D) in Feb 2025, raising $35.0M.